Use of epothilones in the treatment of brain diseases associated with proliferative processes

Details for Australian Patent Application No. 2003215618 (hide)

International Classifications

Event Publications

31 July 2003 Complete Application Filed

Priority application(s): 02004745.2 01.03.02 EP; 60/361,062 01.03.02 US

23 October 2003 Application Open to Public Inspection

Published as AU-B-2003215618

28 May 2009 Alteration of Name

The name of the applicant has been altered to Bayer Schering Pharma Aktiengesellschaft

4 June 2009 Application Accepted

Published as AU-B-2003215618

8 October 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.